Oncology Executive Team
Keri Stirling-Coe
Head of Corporate Accounts & Trade
Keri Stirling-Coe leads Acrotech Biopharma’s corporate accounts and trade strategy, overseeing contracting initiatives and distribution channel decisions across the company’s portfolio.
With more than 20 years of experience in the pharmaceutical industry, including over a decade dedicated to hematology and oncology, she brings extensive expertise in corporate account management, strategic contracting, and market access. Keri brings valuable institutional knowledge and a deep understanding of the company’s products and customers. She has worked with Acrotech’s oncology portfolio for over a decade and is committed to building strong partnerships and advancing customer- and patient-centered strategies that support the needs of the healthcare community.
Paul Mingmongkol
Head of Marketing
Paul Mingmongkol serves as Head of Marketing at Acrotech Biopharma, where he leads the overall marketing strategy for the company’s oncology and dermatology portfolio. An industry veteran with more than 25 years industry experience, Paul has held leadership roles in sales, sales management, training, and marketing spanning both small biotechnology and large pharmaceutical organizations.
Prior to joining Acrotech, Paul held leadership positions at Bristol Myers Squibb, where he led U.S. Professional Marketing for Renal Transplant and later served on the U.S. Immuno-Oncology Commercial Biomarkers team. His commercial experience spans multiple therapeutic areas, including twelve years in oncology. Paul’s expertise in strategic marketing and brand commercialization supports Acrotech’s continued growth and portfolio expansion.
Paula Eason, PhD
Head of Medical Affairs
Paula Eason serves as Head of Medical Affairs at Acrotech Biopharma, where she leads the Medical Affairs organization and oversees the development and execution of medical strategy across the company’s oncology and dermatology portfolio. With more than 25 years of experience spanning the pharmaceutical industry, biotechnology, diagnostics, and public-private partnerships, Paula brings extensive expertise in Medical Affairs and scientific leadership.
Prior to joining Acrotech, Paula held leadership roles at AstraZeneca and Ipsen, leading both U.S. and international medical teams to launch complex specialty assets, lifecycle management, evidence generation programs, and external scientific engagement initiatives. She remains deeply committed to patient-centric advocacy and scientific rigor. Her experience in building medical strategies and supporting successful product commercialization supports advancing Acrotech’s growth objectives.
Scott Komorous
Head of Oncology Sales
Scott Komorous serves as Head of Oncology Sales at Acrotech Biopharma, where he leads the commercial sales strategy and execution for the company’s oncology portfolio. With more than 30 years of experience in the pharmaceutical industry, Scott has built a distinguished career spanning sales leadership, commercial operations, and sales training.
Throughout his career, Scott has held a variety of leadership roles and played a key role in the successful launch of several important oncology products. He has demonstrated a strong commitment to building high-performing teams and delivering impactful commercial results in competitive markets.











